Amphastar Pharmaceuticals (AMPH) Other Non Operating Income (2013 - 2026)

Amphastar Pharmaceuticals' Other Non Operating Income history runs 14 years deep, the most recent figure standing at $575000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 125.74% year-over-year to $575000.0 in Q1 2026; TTM through Mar 2026 was $3.3 million, a 181.66% increase from a year earlier, with the FY2025 full-year figure at $522000.0, down 87.19% from the prior year.
• Other Non Operating Income fell to $575000.0 in Q1 2026 per AMPH's latest filing, from $1.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $7.6 million in Q1 2022 and bottomed at -$5.5 million in Q4 2023.
• The 5-year median for Other Non Operating Income is $298000.0 (2024), against an average of $606588.2.
• Across the five-year window, Other Non Operating Income sank 262.38% in 2023 and soared 1618.21% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $3.4 million in 2022, then sank by 262.38% to -$5.5 million in 2023, then surged by 153.83% to $3.0 million in 2024, then plunged by 65.64% to $1.0 million in 2025, then tumbled by 43.29% to $575000.0 in 2026.
• Per Business Quant, the three latest AMPH Other Non Operating Income figures stand at $575000.0 (Q1 2026), $1.0 million (Q4 2025), and $231000.0 (Q3 2025).